References
- Weetman A P, McGregror A M, Hall R. Evidence for an effect of antithyroid drugs on the natual history of Graves' disease. Clin Endocrinol (Oxf) 1984; 21: 163–72
- Pinchera A, Liberti P, Martino E, Fenzi G F, Grasso L, Rovis L, et al. Effects of antithyroid therapy on the long acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metab 1969; 29: 231–8
- McGregor A M, Peterson M M, McLachlan S M, Rooke P, Rees Smith B, Hall R. Carbamizole and the autoimmune response in Graves' disease. New Engl J Med 1980; 303: 302–7
- McGregor A M, Ibbertson H K, Rees Smith B, Hall R. Carbimazole and autoantibody synthesis in Hashimoto's thyroiditis. Brit Med J 1980; 281: 968–9
- Jansson R, Karlsson A, Dahlberg P A. Thyroxine, methimazole and thyroid microsomal autoantibody titres in hypothyroid Hashimoto's thyroiditis. Brit Med J 1985; 290: 11–12
- Rennie D P, McGregor A M, Keast D, Weetman A P, Foord S M, Dieguez C, et al. The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology 1983; 112: 326–30
- Davies T F, Weiss I, Gerber M A. Influence of methimazole on murine thyroiditis. Evidence for imunosupression in vivo. J Clin Invest 1984; 73: 397–404
- Cohen S B, Weetman A P. Characterization of different types of experimental autoimmune thyroiditis in the Buffalo strain rat. Clin Exp Immunol 1987; 69: 25–32
- Volpé R, Karlsson A, Jansson R, Dahlberg P A. Evidence that antithyroid drugs induce remissions in Graves' disease by modulating thyroid cellular activity. Clin Endocrinol (Oxf) 1986; 25: 453–62
- Tötterman T H, Karlsson F A, Bengtsson M, Mendel-Hartvig I. Induction of circulating activated suppressor-like T-cells by methimazole therapy for Graves' disease. New Engl J. Med 1987; 316: 15–22
- Botazzo G F, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; 2: 1111–5
- Minami M, Ebner S A, Stadecker M J, Dorf M E. The effects of phorbol ester on alloantigen presentation. J Immunol 1987; 138: 393–400
- Ambesi-Impiombato F S, Parks L AM, Coon H G. Culture of hormone dependent epithelial cells from rat thyroids. Proc Natl Acad Sci USA 1980; 77: 3455–9
- Weetman A P, Green C, Borysiewicz L K. The regulation of class II major histocompatibility antigen expression in FRTL5 thyroid cells. J Endocrinol, in press
- Silverman D A, Rose N R. Neonatal thymectomy increases the incidence of spontaneous and methyl-cholanthrene enhanced thyroiditis in rats. Science 1974; 184: 162–3
- Weetman A P, McGregor A M, Rennie D P, Hall R. Sites of autoantibody production in rats with thyroiditis. Immunology 1982; 46: 465–72
- Jansson R, Karlsson A, Forsum U. Intrathyroidal HLA-DR expression and lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin Exp Immunol 1984; 58: 264–72
- Weetman A P, Volkman D J, Burman K D, Gerrard T L, Fauci A S. The in vitro regulation of human thyrocyte HLA-DR antigen expression. J Clin Endrocrinol Metab 1985; 61: 817–24
- Iwatani Y, Gerstein H, Iitaka M, Row W, Volpé R. Thyrocyte HLA-DR expression induced by autologous Graves' lymphocytes and supernatants from mitogen stimulated lymphocytes. J Clin Endocrinol Metab 1986; 63: 695–708
- Ludgate M E, McGregor A M, Weetman A P, Ratanachaiyavong S, Hall R, Lazarus J H, et al. T-cell subset analysis in Graves' disease; alterations associated with carbimazole therapy. Brit Med J 1984; 288: 256–30